Cited by

• Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.

  Titeler M, Seeman P. Titeler M, et al. Proc Natl Acad Sci U S A. 1978 May;75(5):2249-53. doi: 10.1073/pnas.75.5.2249. Proc Natl Acad Sci U S A. 1978. PMID: 27786 Free PMC article.
• Evidence for a dopaminergic dominance in the 4,alpha-dimethyl-m-tyramine-induced hypermotility in mice.

  Rüdeberg C. Rüdeberg C. Psychopharmacology (Berl). 1978 Dec 8;59(3):247-54. doi: 10.1007/BF00426629. Psychopharmacology (Berl). 1978. PMID: 32571 No abstract available.
• Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285.

  Dumuis A, Gozlan H, Sebben M, Ansanay H, Rizzi CA, Turconi M, Monferini E, Giraldo E, Schiantarelli P, Ladinsky H, et al. Dumuis A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Mar;345(3):264-9. doi: 10.1007/BF00168685. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1320204
• KW-3902, a selective high affinity antagonist for adenosine A1 receptors.

  Nonaka H, Ichimura M, Takeda M, Kanda T, Shimada J, Suzuki F, Kase H. Nonaka H, et al. Br J Pharmacol. 1996 Apr;117(8):1645-52. doi: 10.1111/j.1476-5381.1996.tb15335.x. Br J Pharmacol. 1996. PMID: 8732272 Free PMC article.
• Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II.

  Palluk R, Hoefke W, Gaida W, Mierau J, Bechtel WD. Palluk R, et al. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):277-83. doi: 10.1007/BF00512941. Naunyn Schmiedebergs Arch Pharmacol. 1986. PMID: 3020439